Health

Hims & Hers Pulls Knockoff Obesity Pill Amid Regulatory Pressure

Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill The New York TimesHims & Hers pulls copycat weight-loss pill after threats of legal action CNBCHims to stop offering GLP-1 pill after FDA warned of crackdown ReutersHers Expands…

By Dr Natalie Singh - Health Editor Updated February 8, 2026

Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill The New York Times
Hims & Hers pulls copycat weight-loss pill after threats of legal action CNBC
Hims to stop offering GLP-1 pill after FDA warned of crackdown Reuters
Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month investors.hims.com
Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill ABC News

date:2026-02-07 23:19:00

Worth a look

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”